2021/07/09 10:13 A health worker prepares to administer a jab of the AstraZeneca COVID-19 vaccine during a vaccination drive for people ages 30 to 39 in Mexico City, W. A health worker prepares to administer a jab of the AstraZeneca COVID-19 vaccine during a vaccination drive for people ages 30 to 39 in Mexico City, Wednesday, July 7, 2021. (AP Photo/Marco Ugarte) In this March 2021 photo provided by Pfizer, vials of the Pfizer-BioNTech COVID-19 vaccine are prepared for packaging at the company’s facility in Puu. In this March 2021 photo provided by Pfizer, vials of the Pfizer-BioNTech COVID-19 vaccine are prepared for packaging at the company’s facility in Puurs, Belgium. Pfizer is about to seek U.S. authorization for a third dose of its COVID-19 vaccine, saying Thursday, July 8, 2021, that another shot within 12 months could dramatically boost immunity and maybe help ward off the latest worrisome coronavirus mutant.
Pfizer plans to seek FDA approval for 3rd vaccine dose to boost immunity
In August, Pfizer plans to ask the Food and Drug Administration for emergency authorization of a third dose, Pfizer’s Dr. Mikael Dolsten said. In this March 2021 photo provided by Pfizer, vials of the Pfizer-BioNTech COVID-19 vaccine are prepared for packaging at the company’s facility in Puurs, Belgium. Pfizer via AP July 8, 2021 | 6:06 PM
Email
Pfizer is about to seek U.S. authorization for a third dose of its COVID-19 vaccine, saying Thursday that another shot within 12 months could dramatically boost immunity and maybe help ward off the latest worrisome coronavirus mutant.
Pfizer is about to seek US authorisation for a third dose of its COVID-19 vaccine, saying Thursday that another shot within 12 months could dramatically boost immunity and maybe help ward off the latest worrisome coronavirus mutant. Research from multiple countries shows the Pfizer shot and other widely used COVID-19 vaccines offer strong protection against the highly contagious delta variant, which is spreading rapidly around the world and now accounts for most new U.S. infections. Two doses of most vaccines are critical to develop high levels of virus-fighting antibodies against all versions of the coronavirus, not just the delta variant and most of the world still is desperate to get those initial protective doses as the pandemic continues to rage.
Pfizer To Seek Authorisation For A Third Covid Vaccine Dose
Two doses of most vaccines are critical to develop high levels of virus-fighting antibodies against all versions of the coronavirus, not just the delta variant and most of the world still is desperate to get those initial protective doses as the pandemic continues to rage.
Associated Press (AP) 09 July 2021, Last Updated at 7:57 am File Photo Associated Press (AP) 2021-07-09T07:52:17+05:30 Pfizer To Seek Authorisation For A Third Covid Vaccine Dose outlookindia.com 2021-07-09T07:57:47+05:30
Also read
Pfizer is about to seek US authorisation for a third dose of its COVID-19 vaccine, saying Thursday that another shot within 12 months could dramatically boost immunity and maybe help ward off the latest worrisome coronavirus mutant.
Hannah Martin Lauran Neergaard15:35, Jul 09 2021
STUFF
There are 10 ingredients in the Pfizer Covid-19 vaccine. A microchip is not one of them.
New Zealand s medicines safety agency is seeking information from drug company Pfizer after it declared its intent to seek the OK for a third dose of its Covid-19 vaccine overseas. On Friday, international media outlets reported the pharmaceutical firm is set to seek emergency authorisation for a third dose of its Covid-19 vaccine in the United States, for better protection against emerging variants. Medsafe group manager Chris James told
Stuff any change to vaccine dosing or frequency of dosing would require data to be submitted to regulators to vary the provisional approval.